tyrosine has been researched along with Hematologic Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chavez, SA; Estrada Jimenez, VH; Kirken, RA; Li, L; Rodriguez Moncivais, OJ; Rodriguez, G; Sun, S | 1 |
Goyama, S; Huang, G; Kurokawa, M; Mulloy, JC | 1 |
Avila, R; Barroeta, A; Chirinos, P; Compagnone, RS; De Sanctis, JB; Martinez, GP; Mijares, MR; Ochoa, M; Suarez, AI | 1 |
Gilliland, DG; Ihle, JN | 1 |
2 review(s) available for tyrosine and Hematologic Neoplasms
Article | Year |
---|---|
Posttranslational modifications of RUNX1 as potential anticancer targets.
Topics: Animals; Antineoplastic Agents; Base Sequence; Carcinogenesis; Core Binding Factor Alpha 2 Subunit; Hematologic Neoplasms; Humans; Lysine; Molecular Sequence Data; Molecular Targeted Therapy; Protein Processing, Post-Translational; Tyrosine | 2015 |
Jak2: normal function and role in hematopoietic disorders.
Topics: Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Janus Kinase 2; Models, Molecular; Mutation; Myeloproliferative Disorders; Phosphorylation; Protein Structure, Tertiary; Receptors, Cytokine; Signal Transduction; Translocation, Genetic; Tyrosine | 2007 |
2 other study(ies) available for tyrosine and Hematologic Neoplasms
Article | Year |
---|---|
Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies.
Topics: Animals; Drug Development; Hematologic Neoplasms; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinases; Mice; Mutation; Receptors, Interferon; Tyrosine | 2023 |
Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines.
Topics: Antibiotics, Antineoplastic; Apoptosis; Biological Products; Cell Cycle; Cell Proliferation; Cell Survival; Flow Cytometry; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Jurkat Cells; Tyrosine; U937 Cells | 2013 |